Back
Citius Pharmaceuticals 10K Form
Sell
28
CTXR
Citius Pharmaceuticals
Last Price:
0.65
Seasonality Move:
-21.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CTXR News And Ratings
See the #1 stock for the next 7 days that we like better than CTXR
CTXR Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-7.79M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.50 |
| Price / Book: | 1.48 |
Profitability
| EPS (TTM): | -0.24000 |
|---|---|
| Net Income (TTM): | $-36.2M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Citius Pharmaceuticals Earnings Forecast
Key Citius Pharmaceuticals Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 12 years have been positive in 6 years.
Citius Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CTXR |
| CUSIP: | 17322U |
| Website: | citiuspharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 7.2 |
CTXR Technical Analysis vs Fundamental Analysis
Sell
28
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy or a Sell?
-
Citius Pharmaceuticals stock is rated a Sell
The current Citius Pharmaceuticals [CTXR] share price is $0.65. The Score for CTXR is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.